For patients with type 2 diabetes and elevated systolic blood pressure, an intensive-treatment strategy is better t ...

KIRO 7′s Ranji Sinha looks at some of the major developments to fight diabetes in this week’s Healthier Together.

Metformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering ...

New research shows that diabetes rates have doubled to 800 million adults, but over half remain untreated. Read now!

Global diabetes rates quadrupled since 1990, affecting 828 million adults, with treatment disparities persisting.

An intensive treatment approach to lowering high systolic blood pressure in people with Type 2 diabetes led to a reduced risk of heart attack, stroke, heart failure and death due to cardiovascular ...

There are ways to avoid getting diabetes, but if you are unlucky enough to develop it, it can be managed, which is important ...

Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China ...

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

Analyst Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Biomea Fusion (BMEA – Research Report) and keeping the price target at ...